medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 587

Rev Med Cos Cen 2009; 66 (587)

Mononucleosis infecciosa

Lara VHP
Full text How to cite this article

Language: Spanish
References: 20
Page: 73-77
PDF size: 222.32 Kb.


Key words:

No keywords

ABSTRACT

Infectious mononucleosis (IM) is a clinical syndrome caused by Epstein-Barr virus (EBV). Whereas most EBV infections of infants and children are asymptomatic or have nonspecific symptoms, infections of adolescents and adults frequently result in IM, with classic symptoms like: sore throat, lymph node enlargement, fever, and tonsillar enlargement. The mainstay of treatment for IM is supportive care.


REFERENCES

  1. Ambinder R, Lin L. Mononucleosis in the Laboratory. JID 2005; 192: 1503-4.

  2. Bottieau E et al . Infectious Mononuc leosis-Like Syndromes en Febrile Travelers Returning From the Tropics. Journal of Travel Medicine 2006; 13: 191-97.

  3. Chapman A, Watkin R, Ellis C. Lesson of the Week: Abdominal Pain in Acute Infectious Mononucleosis. BMJ 2002; 324: 660-661.

  4. Cohen J. Epstein-Barr Virus Infection. NEJM 2000; 343: 481-89.

  5. Crawford D et al. Sexual History and Epstein-Barr Virus Infection. JID 2002; 186: 731-6.

  6. Duca K et al. A Virtual Look at Epstein-Barr Virus Infection: Biological Interpretations. Plos Pathogens 2007; 3: e137. doi:10.1371/journal.ppat.0030137.

  7. Ebell M. Epstein-Barr Virus Infectious Mononucleosis. American Family Physician 2004; 40: 1279-87.

  8. Fachiroh J et al. Molecular Diversity of Epstein-Barr Virus IgG and IgA Antibody Responses in Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese, and European Subjects. JID 2004; 190: 53-62.

  9. Fafi-Kremer S et al. Long-Term Shedding of Infectious Epstein-Barr Virus After Infectious Mononucleosis. JID 2005; 191: 985-9.

  10. Farrel P. Role for HLA in Susceptibility to Infectious Mononucleosis. J. Clin. Invest 2007; 117: 2756-2758.

  11. Higgins C et al. A Study of Risk Factors for Adquisition of Epstein-Barr Virus and Its Subtypes. JID 2007; 195: 474-82.

  12. Lawee D. Mild Infectious Mononucleosis Presenting with Transient Mixed Liver Disease. Canadian Family Physician 2007; 53: 1314-16.

  13. Macsween K, Crawford D. Epstein-Barr – Recent Advances. The Lancet Infectious Diseases 2003; 3: 131-38.

  14. Moss D, Suhrbier A, Elliott S. Candidate Vaccines for Epstein-Barr Virus. BMJ 1998; 317: 423-24.

  15. Seok I. Proteinuria in a Boy with Infectious Mononucleosis, C1q Nephropathy and Dent’s Disease. J Korean Med Sci 2007; 22: 928-31.

  16. Sitki-Green D et al. Biology of Epstein-Barr Virus During Infectious Mononucleosis. JID 2004; 189: 483-92.

  17. Stephenson J, DuBois J. Nonoperative Management of Spontaneous Splenic Rupture in Infectious Mononucleosis: A Case Report and Review of the Literature. Pediatrics 2007; 120: e432-e435.

  18. Taga K, Tosato G. Diagnosis of Atypical Cases of Infectious Mononucleosis. CID 2001; 33: 83-8.

  19. Taylor G. Cytomegalovirus. American Family Physician 2003; 67: 519-24.

  20. Zanghellini F et al. AsymptomaticPrimary Cytomegalovirus Infection: Virologic and Immunologic Features. JID 1999; 180: 702-7.




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

Rev Med Cos Cen. 2009;66